TARA 8-K 2026-08-11

Protara Therapeutics, Inc. (TARA) 8-K dated 2026-08-11 — accession 0001213900-26-087506.

Protara Therapeutics, Inc. (TARA) is a biotechnology company listed on NASDAQ.

Protara Therapeutics, Inc. filed a 8-K on 2026-08-11. Accession 0001213900-26-087506.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for TARA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The TARA SEC hub lists recent forms. The stock page is the research view.